Targeted Anticancer Agent with Original Mode of Action Prepared by Supramolecular Assembly of Antibody Oligonucleotide Conjugates and Cationic Nanoparticles

Despite their clinical success, Antibody-Drug Conjugates (ADCs) are still limited to the delivery of a handful of cytotoxic small-molecule payloads. Adaptation of this successful format to the delivery of alternative types of cytotoxic payloads is of high interest in the search for novel anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehot, Victor, Neuberg, Patrick, Ripoll, Manon, Daubeuf, François, Erb, Stéphane, Dovgan, Igor, Ursuegui, Sylvain, Cianférani, Sarah, Kichler, Antoine, Chaubet, Guilhem, Wagner, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305667/
https://www.ncbi.nlm.nih.gov/pubmed/37376091
http://dx.doi.org/10.3390/pharmaceutics15061643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305667/
https://www.ncbi.nlm.nih.gov/pubmed/37376091
http://dx.doi.org/10.3390/pharmaceutics15061643

Ejemplares similares